Table 1.
Association between fibulin 2 protein expression and clinicopathological parameters in primary lung tumors.
Fibulin 2 | |||||
---|---|---|---|---|---|
Negative | Positive | p-Value | |||
Type | ADC | 28 | 24 | ||
SCC | 14 | 28 | 0.047 | ||
Methylation status | Unmethylation | 4 | 3 | Fisher’s | |
Partial methylation and methylation | 15 | 15 | 1 | ||
Gender | Male | 29 | 39 | ||
Female | 14 | 14 | 0.51 | ||
Age | ≤65 | 34 | 42 | ||
>65 | 9 | 11 | 0.983 | ||
pT | 1–2 | 42 | 45 | Fisher’s | |
3–4 | 2 | 10 | 0.061 | ||
pN | 0–1 | 27 | 39 | ||
2–4 | 16 | 14 | 0.257 | ||
pM | 0 | 40 | 49 | Fisher’s | |
1–3 | 3 | 4 | 1 | ||
Grade | 1–2 | 20 | 28 | ||
3–4 | 23 | 25 | 0.538 |
ADC, adenocarcinoma; SCC, squamous cell carcinoma. pT: tumor size; pN: tumor invasion in lymph node; pM: tumor metastasis.